Jamie A. Donadio
2017
In 2017, Jamie A. Donadio earned a total compensation of $650K as Senior Vice President and Chief Financial Officer at Mirati Therapeutics, a 48% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,600 |
|---|---|
| Option Awards | $211,900 |
| Salary | $330,000 |
| Other | $2,500 |
| Total | $650,000 |
Donadio received $330K in salary, accounting for 51% of the total pay in 2017.
Donadio also received $105.6K in non-equity incentive plan, $211.9K in option awards and $2.5K in other compensation.
Rankings
In 2017, Jamie A. Donadio's compensation ranked 10,900th out of 14,666 executives tracked by ExecPay. In other words, Donadio earned more than 25.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,900 out of 14,666 | 26th |
Division Manufacturing | 4,247 out of 5,768 | 26th |
Major group Chemicals And Allied Products | 1,522 out of 2,074 | 27th |
Industry group Drugs | 1,246 out of 1,730 | 28th |
Industry Pharmaceutical Preparations | 968 out of 1,329 | 27th |
Source: SEC filing on April 19, 2019.
Donadio's colleagues
We found four more compensation records of executives who worked with Jamie A. Donadio at Mirati Therapeutics in 2017.
2017
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2017
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2017
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2017
Chris LeMasters
Mirati Therapeutics